论文部分内容阅读
目的:探讨反流性食管炎的临床用药的选择和临床疗效。方法:把经过临床理化检查确诊的56例反流性食管炎患者随机分为两组,一组运用多潘立酮和雷尼替丁。二组运用西沙必利和奥美拉唑。治疗8周后观察两组患者的疗效。结果:两组患者的总有疗效分别为78.57%,96.43%,两者比较差异有统计学意义(P>0.05)。停药后观察4周,两组患者复发率相似,无统计学意义。结论:质子泵抑制剂及胃肠动力药物的联合运用对反流性食管炎有显著的临床疗效,优于H2受体拮抗剂。但停药后易复发,应连续维持用药8月以上。
Objective: To investigate the clinical choice and clinical efficacy of reflux esophagitis. Methods: Fifty-six patients with reflux esophagitis diagnosed by clinical physical and chemical tests were randomly divided into two groups, one using domperidone and ranitidine. The second group used cisapride and omeprazole. After 8 weeks of treatment, the curative effect of both groups was observed. Results: The total effective rates of the two groups were 78.57% and 96.43% respectively, with significant difference between the two groups (P> 0.05). Observed after stopping 4 weeks, the recurrence rate of two groups of patients was similar, not statistically significant. Conclusion: The combined use of proton pump inhibitor and gastrointestinal motility drug has significant clinical effect on reflux esophagitis, which is better than H2 receptor antagonist. However, relapse after stopping drug should be continued for more than August medication.